Tikehau's Chabran Weighs In as Private Credit Concerns Rise
BloombergDuration: 8:34
Read the full storyUp next
- Merck, Moderna Stocks Soar After Melanoma Trial Success
- Lerner: Give Bull Market Benefit of the Doubt
- SK Hynix Announces $29 Billion Share Buyback Plan
- When the Bond Market Speaks, People Listen, TD's Goldberg Says
- Merck, Moderna Melanoma Vaccine Study Succeeds
- September Rate Hike Isn't Too Bad of an Idea, Bullard Says
